Media Centre
Latest press releases
-
US FDA approves Tagrisso as 1st-line treatment for EGFR-mutated non-small cell lung cancer
-
Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR
-
1st-line Tagrisso demonstrates sustained benefit post progression in patients with EGFR-mutated non-small cell lung cancer
-
AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
-
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Esra Erkal-Paler
Global Head of External Communications
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
